The use of medical cannabis is gaining traction for managing a wide range of conditions, from pain to stress. However, determining the right dosage remains a significant challenge.
Factors such as individual metabolism, tolerance levels, and body composition can influence how product potency affects individuals. While you can use these factors to make an educated guess on dosage, pinpointing the ideal potency level often takes experimentation.
However, artificial intelligence
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Promise Bio Secures $8.3M for Auto-Immune Precision Medicine Platform
What You Should Know:
- Promise Bio, a startup transforming immune-mediated disease treatment with advanced precision medicine solutions, today announced its emergence from stealth with an $8.3 million seed investment.
- This funding will accelerate the development of Promise Bio's computational platform, which uses epiproteomics and artificial intelligence to predict patient treatment responses and support drug research and development.
Revolutionizing Immune-Mediated Disease
Read More
Pleno Closes $25M Series B & Appoints Dr. Vik Vaz as CEO
What You Should Know:
- Pleno, an innovative multi-omics diagnostics company, announced it has raised $25M in Series B funding and appointed Dr. Vik Vaz as its new Chief Executive Officer (CEO). Key investors Deerfield Management, Foresite Capital and Medical Excellence Capital remain committed to supporting the next phase of the company’s growth strategy.
- Dr. Vaz, a seasoned leader with extensive experience in the life sciences and medical technology sectors, will guide
Read More
Capstan Medical Raises $110M to Advance Minimally Invasive Heart Valve Treatment
What You Should Know:
- Capstan Medical, a medical technology company developing innovative solutions for heart valve disease secures $110M in a Series C funding round led by Eclipse with participation from existing investors Yu Galaxy and Intuitive Ventures, and new investment from Gideon Strategic Partners.
- Capstan Medical is developing a suite of next-generation heart valve implants and a first-of-its-kind catheter-based robotic delivery platform.
Addressing the Global Burden
Read More
Nucs AI Secures $3.5M to Advance AI-Powered Prostate Cancer Diagnostics
What You Should Know:
- Nucs AI, a company that uses AI in precision medicine for the diagnosis and treatment of prostate cancer, today announces that it has closed a $3.5 million seed round of funding.
- The company will use the funding to further build out its platform and to support FDA clearance for its technology in the United States.
Nucs AI: Transforming Prostate Cancer Diagnosis and Treatment with Precision Medicine
Founded in 2023, Nucs AI is pioneering advancements in
Read More
H1 and CTI Partner for Clinical Trial Optimization
What You Should Know:
- H1, on a mission to connect the world to the right doctors, today announced a strategic partnership with CTI Clinical Trial & Consulting Services (CTI), a leading global full-spectrum research service provider.
- Through this partnership, CTI will leverage H1’s Trial Landscape platform to drive data-informed clinical trial planning and execution to enhance strategic feasibility, real-world evidence, and clinical trial execution on a global scale. This
Read More
Carta Healthcare Acquires Realyze Intelligence to Enhance AI-Powered Clinical Trial Matching
What You Should Know:
- Carta Healthcare®, which ignites healthcare improvement by unlocking the power of clinical data, expanded the strength and capabilities of its AI-powered platform with the acquisition of Realyze Intelligence.
- The Realyze Intelligence solution leverages AI to match patients to clinical trials to accelerate research and reduce costs while providing patients with the latest advances in care.
Carta Healthcare and Realyze Intelligence:
Read More
Certis Oncology Launches AI-Powered Chatbot for Cancer Research
What You Should Know:
- Certis Oncology Solutions, a translational science and emerging technology leader in preclinical oncology research, is pleased to announce the commercial launch of CertisOI Assistant™, an innovative chatbot tool designed to enhance the efficiency and effectiveness of cancer research.
- This cutting-edge research tool leverages artificial intelligence/machine learning (AI/ML) and OpenAI’s ChatGPT language model to provide researchers unparalleled insights
Read More
How Pharma Can Enhance Infusion Clinic Operations and Patient Care
Infusion Clinics (ICs) face a delicate balancing act. They must strive for operational excellence while simultaneously navigating the realities of competition, patient care challenges, and compliance requirements. It’s a difficult challenge, and as ICs adapt to evolving demands, there’s a growing need for pharmaceutical manufacturers to step up with tailored support.
From streamlining medication access to advocating for policy changes, manufacturers can significantly impact how ICs
Read More
ConcertAI & NeoGenomics Launch CTO-H for Hematology Research
What You Should Know:
- ConcertAI and NeoGenomics (NASDAQ: NEO) announce a joint software-as-a-service solution in hematological malignancies for research analytics, clinical trial design, and clinical trial operational optimization.
- CTO-H provides a research data solution that is unprecedented in its scale, longitudinality and biomarker depth. CTO-H is a major outcome of the collaboration jointly announced on Jan. 8, 2024, and the more recent joint research completed and scheduled for
Read More